Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2). [electronic resource]

By: Contributor(s): Producer: 20130214Description: 1490-502 p. digitalISSN:
  • 1556-1380
Subject(s): Online resources: In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 7
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.